stella
beta
An Exploratory, Multi-cohort Phase II Study of Combination Therapy With AK104 and AK112 for Recurrent Ovarian Cancer — Stella
Recruiting
Back to Recurrent Ovarian Cancer trials
Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations
(1 site)
China
Fudan University Shanghai Cancer Center, Shanghai
View full record on ClinicalTrials.gov